TY - JOUR AU - Rajwanshi, A. AU - Srinivas, R. AU - Upasana, G. PY - 2009 DA - 2009// TI - Malignant small round cell tumors JO - J Cytol VL - 26 UR - https://doi.org/10.4103/0970-9371.54861 DO - 10.4103/0970-9371.54861 ID - Rajwanshi2009 ER - TY - JOUR AU - Rong, R. PY - 2009 DA - 2009// TI - Metastatic poorly differentiated monophasic synovial sarcoma to lung with unknown primary: a molecular genetic analysis JO - Int J Clin Exp Pathol VL - 3 ID - Rong2009 ER - TY - JOUR AU - Thway, K. AU - Fisher, C. PY - 2014 DA - 2014// TI - Synovial sarcoma: defining features and diagnostic evolution JO - Ann Diagn Pathol VL - 18 UR - https://doi.org/10.1016/j.anndiagpath.2014.09.002 DO - 10.1016/j.anndiagpath.2014.09.002 ID - Thway2014 ER - TY - JOUR AU - Kimura, T. PY - 2016 DA - 2016// TI - Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells JO - Oncogene VL - 35 UR - https://doi.org/10.1038/onc.2015.461 DO - 10.1038/onc.2015.461 ID - Kimura2016 ER - TY - JOUR AU - Eilber, F. C. AU - Dry, S. M. PY - 2008 DA - 2008// TI - Diagnosis and management of synovial sarcoma JO - J Surg Oncol VL - 97 UR - https://doi.org/10.1002/jso.20974 DO - 10.1002/jso.20974 ID - Eilber2008 ER - TY - JOUR AU - Sultan, I. PY - 2009 DA - 2009// TI - Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients JO - Cancer VL - 115 UR - https://doi.org/10.1002/cncr.24424 DO - 10.1002/cncr.24424 ID - Sultan2009 ER - TY - JOUR AU - Krieg, A. H. PY - 2011 DA - 2011// TI - Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdq394 DO - 10.1093/annonc/mdq394 ID - Krieg2011 ER - TY - JOUR AU - Deshmukh, R. AU - Mankin, H. J. AU - Singer, S. PY - 2004 DA - 2004// TI - Synovial sarcoma: the importance of size and location for survival JO - Clin Orthop Relat Res VL - 419 UR - https://doi.org/10.1097/00003086-200402000-00025 DO - 10.1097/00003086-200402000-00025 ID - Deshmukh2004 ER - TY - JOUR AU - Vlenterie, M. PY - 2016 DA - 2016// TI - Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity JO - Eur J Cancer VL - 58 UR - https://doi.org/10.1016/j.ejca.2016.02.002 DO - 10.1016/j.ejca.2016.02.002 ID - Vlenterie2016 ER - TY - JOUR AU - Salah, S. PY - 2013 DA - 2013// TI - Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen JO - Med Oncol VL - 30 UR - https://doi.org/10.1007/s12032-013-0639-z DO - 10.1007/s12032-013-0639-z ID - Salah2013 ER - TY - JOUR AU - Amankwah, E. K. AU - Conley, A. P. AU - Reed, D. R. PY - 2013 DA - 2013// TI - Epidemiology and therapies for metastatic sarcoma JO - Clin Epidemiol VL - 5 ID - Amankwah2013 ER - TY - JOUR AU - Spurrell, E. L. PY - 2005 DA - 2005// TI - Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital JO - Ann Oncol VL - 16 UR - https://doi.org/10.1093/annonc/mdi082 DO - 10.1093/annonc/mdi082 ID - Spurrell2005 ER - TY - JOUR AU - Corey, R. M. AU - Swett, K. AU - Ward, W. G. PY - 2014 DA - 2014// TI - Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database report JO - Cancer Med VL - 3 UR - https://doi.org/10.1002/cam4.288 DO - 10.1002/cam4.288 ID - Corey2014 ER - TY - JOUR AU - Vlenterie, M. AU - Jones, R. L. AU - Graaf, W. T. PY - 2015 DA - 2015// TI - Synovial sarcoma diagnosis and management in the era of targeted therapies JO - Curr Opin Oncol VL - 27 UR - https://doi.org/10.1097/CCO.0000000000000198 DO - 10.1097/CCO.0000000000000198 ID - Vlenterie2015 ER - TY - JOUR AU - Kubo, T. PY - 2015 DA - 2015// TI - Prognostic value of SS18-SSX fusion type in synovial sarcoma; systematic review and meta-analysis JO - Springerplus VL - 4 UR - https://doi.org/10.1186/s40064-015-1168-3 DO - 10.1186/s40064-015-1168-3 ID - Kubo2015 ER - TY - JOUR AU - Kadoch, C. AU - Crabtree, G. R. PY - 2013 DA - 2013// TI - Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma JO - Cell VL - 153 UR - https://doi.org/10.1016/j.cell.2013.02.036 DO - 10.1016/j.cell.2013.02.036 ID - Kadoch2013 ER - TY - JOUR AU - Przybyl, J. PY - 2012 DA - 2012// TI - Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy JO - Sarcoma VL - 2012 UR - https://doi.org/10.1155/2012/249219 DO - 10.1155/2012/249219 ID - Przybyl2012 ER - TY - JOUR AU - Garcia, C. B. AU - Shaffer, C. M. AU - Eid, J. E. PY - 2012 DA - 2012// TI - Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2 JO - BMC Genomics VL - 13 UR - https://doi.org/10.1186/1471-2164-13-189 DO - 10.1186/1471-2164-13-189 ID - Garcia2012 ER - TY - JOUR AU - Su, L. PY - 2012 DA - 2012// TI - Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics JO - Cancer Cell VL - 21 UR - https://doi.org/10.1016/j.ccr.2012.01.010 DO - 10.1016/j.ccr.2012.01.010 ID - Su2012 ER - TY - JOUR AU - Rekhi, B. PY - 2012 DA - 2012// TI - Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas JO - Indian J Med Res VL - 136 ID - Rekhi2012 ER - TY - STD TI - Laporte AN et al. Identification of cytotoxic agents disrupting synovial sarcoma oncoprotein interactions by proximity ligation assay. Oncotarget, 2016;7(23):34384–94. ID - ref21 ER - TY - JOUR AU - Panagopoulos, I. PY - 2001 DA - 2001// TI - Clinical impact of molecular and cytogenetic findings in synovial sarcoma JO - Genes Chromosomes Cancer VL - 31 UR - https://doi.org/10.1002/gcc.1155 DO - 10.1002/gcc.1155 ID - Panagopoulos2001 ER - TY - JOUR AU - Sun, Y. PY - 2009 DA - 2009// TI - Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma JO - Cancer Sci VL - 100 UR - https://doi.org/10.1111/j.1349-7006.2009.01134.x DO - 10.1111/j.1349-7006.2009.01134.x ID - Sun2009 ER - TY - JOUR AU - Ladanyi, M. PY - 2002 DA - 2002// TI - Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients JO - Cancer Res VL - 62 ID - Ladanyi2002 ER - TY - JOUR AU - Takenaka, S. PY - 2008 DA - 2008// TI - Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan JO - Oncol Rep VL - 19 ID - Takenaka2008 ER - TY - JOUR AU - Fricke, A. PY - 2015 DA - 2015// TI - Identification of a blood-borne miRNA signature of synovial sarcoma JO - Mol Cancer VL - 14 UR - https://doi.org/10.1186/s12943-015-0424-z DO - 10.1186/s12943-015-0424-z ID - Fricke2015 ER - TY - JOUR AU - Masliah-Planchon, J. AU - Garinet, S. AU - Pasmant, E. PY - 2016 DA - 2016// TI - RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action JO - Oncotarget VL - 7 ID - Masliah-Planchon2016 ER - TY - JOUR AU - Hisaoka, M. PY - 2011 DA - 2011// TI - Identification of altered MicroRNA expression patterns in synovial sarcoma JO - Genes Chromosomes Cancer VL - 50 UR - https://doi.org/10.1002/gcc.20837 DO - 10.1002/gcc.20837 ID - Hisaoka2011 ER - TY - JOUR AU - Fricke, A. PY - 2016 DA - 2016// TI - Synovial Sarcoma Microvesicles Harbor the SYT-SSX Fusion Gene Transcript: Comparison of Different Methods of Detection and Implications in Biomarker Research JO - Stem Cells Int VL - 2016 UR - https://doi.org/10.1155/2016/6146047 DO - 10.1155/2016/6146047 ID - Fricke2016 ER - TY - JOUR AU - Hashimoto, N. PY - 2001 DA - 2001// TI - Detection of SYT-SSX fusion gene in peripheral blood from a patient with synovial sarcoma JO - Am J Surg Pathol VL - 25 UR - https://doi.org/10.1097/00000478-200103000-00017 DO - 10.1097/00000478-200103000-00017 ID - Hashimoto2001 ER - TY - JOUR AU - Chang, L. PY - 2015 DA - 2015// TI - Circulating tumor cells in sarcomas: a brief review JO - Med Oncol VL - 32 UR - https://doi.org/10.1007/s12032-014-0430-9 DO - 10.1007/s12032-014-0430-9 ID - Chang2015 ER - TY - JOUR AU - Chinen, L. T. PY - 2014 DA - 2014// TI - Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion JO - Onco Targets Ther VL - 7 UR - https://doi.org/10.2147/OTT.S62349 DO - 10.2147/OTT.S62349 ID - Chinen2014 ER - TY - JOUR AU - Chibon, F. PY - 2010 DA - 2010// TI - Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity JO - Nat Med VL - 16 UR - https://doi.org/10.1038/nm.2174 DO - 10.1038/nm.2174 ID - Chibon2010 ER - TY - JOUR AU - Lagarde, P. PY - 2013 DA - 2013// TI - Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.46.0147 DO - 10.1200/JCO.2012.46.0147 ID - Lagarde2013 ER - TY - JOUR AU - Gruneberg, U. PY - 2006 DA - 2006// TI - KIF14 and citron kinase act together to promote efficient cytokinesis JO - J Cell Biol VL - 172 UR - https://doi.org/10.1083/jcb.200511061 DO - 10.1083/jcb.200511061 ID - Gruneberg2006 ER - TY - JOUR AU - Ahmed, S. M. PY - 2012 DA - 2012// TI - KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression JO - J Cell Biol VL - 199 UR - https://doi.org/10.1083/jcb.201206051 DO - 10.1083/jcb.201206051 ID - Ahmed2012 ER - TY - JOUR AU - Vagnarelli, P. PY - 2011 DA - 2011// TI - Repo-Man coordinates chromosomal reorganization with nuclear envelope reassembly during mitotic exit JO - Dev Cell VL - 21 UR - https://doi.org/10.1016/j.devcel.2011.06.020 DO - 10.1016/j.devcel.2011.06.020 ID - Vagnarelli2011 ER - TY - JOUR AU - Hwa, V. AU - Oh, Y. AU - Rosenfeld, R. G. PY - 1999 DA - 1999// TI - The insulin-like growth factor-binding protein (IGFBP) superfamily JO - Endocr Rev VL - 20 ID - Hwa1999 ER - TY - JOUR AU - Chen, D. PY - 2011 DA - 2011// TI - Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2774 DO - 10.1158/1078-0432.CCR-10-2774 ID - Chen2011 ER - TY - JOUR AU - Burger, A. M. PY - 2005 DA - 2005// TI - Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer JO - Eur J Cancer VL - 41 UR - https://doi.org/10.1016/j.ejca.2005.04.023 DO - 10.1016/j.ejca.2005.04.023 ID - Burger2005 ER - TY - JOUR AU - Jiang, W. PY - 2008 DA - 2008// TI - Insulin-like growth factor binding protein 7 mediates glioma cell growth and migration JO - Neoplasia VL - 10 UR - https://doi.org/10.1593/neo.08694 DO - 10.1593/neo.08694 ID - Jiang2008 ER - TY - JOUR AU - Shao, L. PY - 2004 DA - 2004// TI - Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients JO - Endocr Relat Cancer VL - 11 UR - https://doi.org/10.1677/erc.0.0110141 DO - 10.1677/erc.0.0110141 ID - Shao2004 ER - TY - JOUR AU - Gambaro, K. PY - 2015 DA - 2015// TI - Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1138-8 DO - 10.1186/s12885-015-1138-8 ID - Gambaro2015 ER - TY - JOUR AU - Nousbeck, J. PY - 2010 DA - 2010// TI - Insulin-like growth factor-binding protein 7 regulates keratinocyte proliferation, differentiation and apoptosis JO - J Invest Dermatol VL - 130 UR - https://doi.org/10.1038/jid.2009.265 DO - 10.1038/jid.2009.265 ID - Nousbeck2010 ER - TY - JOUR AU - Wajapeyee, N. PY - 2008 DA - 2008// TI - Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7 JO - Cell VL - 132 UR - https://doi.org/10.1016/j.cell.2007.12.032 DO - 10.1016/j.cell.2007.12.032 ID - Wajapeyee2008 ER - TY - JOUR AU - Ahmed, S. PY - 2003 DA - 2003// TI - Proteolytic processing of IGFBP-related protein-1 (TAF/angiomodulin/mac25) modulates its biological activity JO - Biochem Biophys Res Commun VL - 310 UR - https://doi.org/10.1016/j.bbrc.2003.09.058 DO - 10.1016/j.bbrc.2003.09.058 ID - Ahmed2003 ER - TY - JOUR AU - Rao, C. PY - 2014 DA - 2014// TI - High expression of IGFBP7 in fibroblasts induced by colorectal cancer cells is co-regulated by TGF-beta and Wnt signaling in a Smad2/3-Dvl2/3-dependent manner JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0085340 DO - 10.1371/journal.pone.0085340 ID - Rao2014 ER - TY - JOUR AU - Padua, D. AU - Massague, J. PY - 2009 DA - 2009// TI - Roles of TGFbeta in metastasis JO - Cell Res VL - 19 UR - https://doi.org/10.1038/cr.2008.316 DO - 10.1038/cr.2008.316 ID - Padua2009 ER - TY - JOUR AU - Massague, J. PY - 2008 DA - 2008// TI - TGFbeta in Cancer JO - Cell VL - 134 UR - https://doi.org/10.1016/j.cell.2008.07.001 DO - 10.1016/j.cell.2008.07.001 ID - Massague2008 ER - TY - JOUR AU - Pen, A. PY - 2008 DA - 2008// TI - Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling JO - Oncogene VL - 27 UR - https://doi.org/10.1038/onc.2008.287 DO - 10.1038/onc.2008.287 ID - Pen2008 ER - TY - JOUR AU - Benassi, M. S. PY - 2015 DA - 2015// TI - Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcoma JO - Am J Cancer Res VL - 5 ID - Benassi2015 ER - TY - JOUR AU - Palmerini, E. PY - 2015 DA - 2015// TI - Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response? JO - Orphanet J Rare Dis VL - 10 UR - https://doi.org/10.1186/s13023-014-0222-5 DO - 10.1186/s13023-014-0222-5 ID - Palmerini2015 ER - TY - JOUR AU - Wan, X. AU - Helman, L. J. PY - 2007 DA - 2007// TI - The biology behind mTOR inhibition in sarcoma JO - Oncologist VL - 12 UR - https://doi.org/10.1634/theoncologist.12-8-1007 DO - 10.1634/theoncologist.12-8-1007 ID - Wan2007 ER - TY - JOUR AU - Roomi, M. W. PY - 2013 DA - 2013// TI - Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines JO - Int J Oncol VL - 43 ID - Roomi2013 ER - TY - JOUR AU - Willis, B. C. AU - Borok, Z. PY - 2007 DA - 2007// TI - TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease JO - Am J Physiol Lung Cell Mol Physiol VL - 293 UR - https://doi.org/10.1152/ajplung.00163.2007 DO - 10.1152/ajplung.00163.2007 ID - Willis2007 ER - TY - JOUR AU - Benassi, M. S. PY - 2001 DA - 2001// TI - Metalloproteinase expression and prognosis in soft tissue sarcomas JO - Ann Oncol VL - 12 UR - https://doi.org/10.1023/A:1008318614461 DO - 10.1023/A:1008318614461 ID - Benassi2001 ER - TY - JOUR AU - Hidalgo, M. AU - Eckhardt, S. G. PY - 2001 DA - 2001// TI - Development of matrix metalloproteinase inhibitors in cancer therapy JO - J Natl Cancer Inst VL - 93 UR - https://doi.org/10.1093/jnci/93.3.178 DO - 10.1093/jnci/93.3.178 ID - Hidalgo2001 ER - TY - JOUR AU - Ferrari, C. PY - 2004 DA - 2004// TI - Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1–16 years JO - Acta Orthop Scand VL - 75 UR - https://doi.org/10.1080/00016470410001295-1 DO - 10.1080/00016470410001295-1 ID - Ferrari2004 ER - TY - JOUR AU - Benassi, M. S. PY - 2003 DA - 2003// TI - Tissue and serum loss of metalloproteinase inhibitors in high grade soft tissue sarcomas JO - Histol Histopathol VL - 18 ID - Benassi2003 ER - TY - JOUR AU - Moran, A. PY - 2005 DA - 2005// TI - Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer JO - Oncol Rep VL - 13 ID - Moran2005 ER - TY - JOUR AU - Way, G. PY - 2002 DA - 2002// TI - Purification and identification of secernin, a novel cytosolic protein that regulates exocytosis in mast cells JO - Mol Biol Cell VL - 13 UR - https://doi.org/10.1091/mbc.E01-10-0094 DO - 10.1091/mbc.E01-10-0094 ID - Way2002 ER - TY - JOUR AU - Hendrix, A. PY - 2011 DA - 2011// TI - The tumor ecosystem regulates the roads for invasion and metastasis JO - Clin Res Hepatol Gastroenterol VL - 35 UR - https://doi.org/10.1016/j.clinre.2011.05.003 DO - 10.1016/j.clinre.2011.05.003 ID - Hendrix2011 ER - TY - JOUR AU - Lin, S. PY - 2015 DA - 2015// TI - Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis JO - Dis Markers VL - 2015 UR - https://doi.org/10.1155/2015/230703 DO - 10.1155/2015/230703 ID - Lin2015 ER - TY - JOUR AU - Miyoshi, N. PY - 2010 DA - 2010// TI - SCRN1 is a novel marker for prognosis in colorectal cancer JO - J Surg Oncol VL - 101 ID - Miyoshi2010 ER - TY - JOUR AU - Suehara, Y. PY - 2011 DA - 2011// TI - Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics JO - J Proteomics VL - 74 UR - https://doi.org/10.1016/j.jprot.2011.02.033 DO - 10.1016/j.jprot.2011.02.033 ID - Suehara2011 ER - TY - JOUR AU - Wang, W. PY - 2015 DA - 2015// TI - Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications JO - Med Res Rev VL - 35 UR - https://doi.org/10.1002/med.21358 DO - 10.1002/med.21358 ID - Wang2015 ER - TY - JOUR AU - Volkel, P. PY - 2015 DA - 2015// TI - Diverse involvement of EZH2 in cancer epigenetics JO - Am J Transl Res VL - 7 ID - Volkel2015 ER - TY - JOUR AU - Changchien, Y. C. PY - 2012 DA - 2012// TI - Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2) JO - J Transl Med VL - 10 UR - https://doi.org/10.1186/1479-5876-10-216 DO - 10.1186/1479-5876-10-216 ID - Changchien2012 ER - TY - JOUR AU - Kawano, S. PY - 2016 DA - 2016// TI - Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0158888 DO - 10.1371/journal.pone.0158888 ID - Kawano2016 ER - TY - JOUR AU - Ramaglia, M. PY - 2016 DA - 2016// TI - High EZH2 expression is correlated to metastatic disease in pediatric soft tissue sarcomas JO - Cancer Cell Int VL - 16 UR - https://doi.org/10.1186/s12935-016-0338-x DO - 10.1186/s12935-016-0338-x ID - Ramaglia2016 ER - TY - JOUR AU - Yamaguchi, H. AU - Hung, M. C. PY - 2014 DA - 2014// TI - Regulation and Role of EZH2 in Cancer JO - Cancer Res Treat VL - 46 UR - https://doi.org/10.4143/crt.2014.46.3.209 DO - 10.4143/crt.2014.46.3.209 ID - Yamaguchi2014 ER - TY - JOUR AU - Fujii, S. PY - 2008 DA - 2008// TI - Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation JO - J Biol Chem VL - 283 UR - https://doi.org/10.1074/jbc.M800224200 DO - 10.1074/jbc.M800224200 ID - Fujii2008 ER - TY - JOUR AU - Moore, H. M. PY - 2013 DA - 2013// TI - EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis JO - Breast Cancer Res Treat VL - 138 UR - https://doi.org/10.1007/s10549-013-2498-x DO - 10.1007/s10549-013-2498-x ID - Moore2013 ER - TY - JOUR AU - Schultz-Thater, E. PY - 2000 DA - 2000// TI - NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens JO - Br J Cancer VL - 83 UR - https://doi.org/10.1054/bjoc.2000.1251 DO - 10.1054/bjoc.2000.1251 ID - Schultz-Thater2000 ER - TY - JOUR AU - Park, T. S. PY - 2016 DA - 2016// TI - Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers JO - J Immunother VL - 39 UR - https://doi.org/10.1097/CJI.0000000000000101 DO - 10.1097/CJI.0000000000000101 ID - Park2016 ER - TY - JOUR AU - Li, M. PY - 2014 DA - 2014// TI - Effective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2 JO - Mol Cancer VL - 13 UR - https://doi.org/10.1186/1476-4598-13-179 DO - 10.1186/1476-4598-13-179 ID - Li2014 ER - TY - JOUR AU - Giesen, E. PY - 2014 DA - 2014// TI - NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.2101 DO - 10.18632/oncotarget.2101 ID - Giesen2014 ER - TY - JOUR AU - Aung, P. P. PY - 2014 DA - 2014// TI - Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma JO - Hum Pathol VL - 45 UR - https://doi.org/10.1016/j.humpath.2013.05.029 DO - 10.1016/j.humpath.2013.05.029 ID - Aung2014 ER - TY - JOUR AU - Lai, J. P. PY - 2012 DA - 2012// TI - NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target JO - Oncoimmunol VL - 1 UR - https://doi.org/10.4161/onci.21059 DO - 10.4161/onci.21059 ID - Lai2012 ER - TY - JOUR AU - Robbins, P. F. PY - 2011 DA - 2011// TI - Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1 JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.32.2537 DO - 10.1200/JCO.2010.32.2537 ID - Robbins2011 ER - TY - JOUR AU - Xu, C. PY - 2015 DA - 2015// TI - CXCR4 in breast cancer: oncogenic role and therapeutic targeting JO - Drug Des Devel Ther VL - 9 ID - Xu2015 ER - TY - JOUR AU - Dewan, M. Z. PY - 2006 DA - 2006// TI - Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer JO - Biomed Pharmacother VL - 60 UR - https://doi.org/10.1016/j.biopha.2006.06.004 DO - 10.1016/j.biopha.2006.06.004 ID - Dewan2006 ER - TY - JOUR AU - Gangadhar, T. AU - Nandi, S. AU - Salgia, R. PY - 2010 DA - 2010// TI - The role of chemokine receptor CXCR4 in lung cancer JO - Cancer Biol Ther VL - 9 UR - https://doi.org/10.4161/cbt.9.6.11233 DO - 10.4161/cbt.9.6.11233 ID - Gangadhar2010 ER - TY - JOUR AU - Lv, S. PY - 2014 DA - 2014// TI - The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis JO - Histopathology VL - 64 UR - https://doi.org/10.1111/his.12321 DO - 10.1111/his.12321 ID - Lv2014 ER - TY - JOUR AU - Scala, S. PY - 2005 DA - 2005// TI - Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-1887 DO - 10.1158/1078-0432.CCR-04-1887 ID - Scala2005 ER - TY - JOUR AU - Oda, Y. PY - 2009 DA - 2009// TI - Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma JO - Int J Cancer VL - 124 UR - https://doi.org/10.1002/ijc.24128 DO - 10.1002/ijc.24128 ID - Oda2009 ER - TY - JOUR AU - Yuecheng, Y. AU - Xiaoyan, X. PY - 2007 DA - 2007// TI - Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2 JO - Eur J Cancer Prev VL - 16 UR - https://doi.org/10.1097/01.cej.0000236259.88146.a4 DO - 10.1097/01.cej.0000236259.88146.a4 ID - Yuecheng2007 ER - TY - JOUR AU - Uchida, D. PY - 2003 DA - 2003// TI - Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma JO - Exp Cell Res VL - 290 UR - https://doi.org/10.1016/S0014-4827(03)00344-6 DO - 10.1016/S0014-4827(03)00344-6 ID - Uchida2003 ER - TY - JOUR AU - Guo, F. PY - 2016 DA - 2016// TI - CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks JO - Oncogene VL - 35 UR - https://doi.org/10.1038/onc.2015.139 DO - 10.1038/onc.2015.139 ID - Guo2016 ER - TY - JOUR AU - Kim, R. H. AU - Li, B. D. AU - Chu, Q. D. PY - 2011 DA - 2011// TI - The role of chemokine receptor CXCR4 in the biologic behavior of human soft tissue sarcoma JO - Sarcoma VL - 2011 ID - Kim2011 ER - TY - JOUR AU - Murphy, P. M. PY - 2001 DA - 2001// TI - Chemokines and the molecular basis of cancer metastasis JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJM200109133451113 DO - 10.1056/NEJM200109133451113 ID - Murphy2001 ER - TY - JOUR AU - Muller, A. PY - 2001 DA - 2001// TI - Involvement of chemokine receptors in breast cancer metastasis JO - Nature VL - 410 UR - https://doi.org/10.1038/35065016 DO - 10.1038/35065016 ID - Muller2001 ER - TY - JOUR AU - Debnath, B. PY - 2013 DA - 2013// TI - Small molecule inhibitors of CXCR4 JO - Theranostics VL - 3 UR - https://doi.org/10.7150/thno.5376 DO - 10.7150/thno.5376 ID - Debnath2013 ER - TY - JOUR AU - Kim, S. Y. PY - 2008 DA - 2008// TI - Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases JO - Clin Exp Metastasis VL - 25 UR - https://doi.org/10.1007/s10585-007-9133-3 DO - 10.1007/s10585-007-9133-3 ID - Kim2008 ER -